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SUMMARY
The National Breast Screening Programme is an ongoing public health
programme. Women between 50 and 64 years are being invited to attend for
screening at threeyearly intervals. The results ofthefirst 5,000 women screened
in the Eastern Health and Social Services Board's unit arepresented. The breast
cancer detection rate was 7 8 per thousand women screened. The malignant to
benign biopsy rate was greater than 1:1.
INTRODUCTION
The working party chaired by Professor Sir Patrick Forrest was appointed in 1985
to report to the Ministers of Health of England and Wales, Scotland and Northern
Ireland on the feasibility of breast screening. This party published its report in
1986 and recommended the implementation of a National Breast Screening
Programme.' It suggested that all women between the ages of 50 and 64 years
should be invited for a single oblique mammogram at three yearly intervals. The
government accepted this recommendation and agreed to fund the programme.
It was anticipated that this should be fully operational by April 1991. In Northern
Ireland the implementation of the National Breast Screening Programme has
been devolved to Board level. The Eastern Board programme consists of a static
screening unit in the Board Headquarters in Belfast and a mobile screening
unit will be used to provide screening for women in Lisburn, Newtownards,
Downpatrick, Newcastle, Bangor and Portaferry. All assessment clinics take
place in the static unit.
SUBJECTS AND METHODS
All women between theagesof 50and 64 yearswereidentified from theNorthern
Ireland Central Services Agency general practice lists and invited to attend for
screening. A prior notification list was compiled with the names and addresses
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of the eligible women in each practice and this was forwarded to the general
practitioner to ensure that the addresses were correct and that there was no
contraindication to inviting the women for screening. Each woman then received
a letter inviting her to attend for screening at an appointed time. The initial
invitation letter stated that a second attendance may sometimes be required. It
was hoped that, by stating in the initial letterthat screening may require two visits,
some of the anxiety generated by recall for assessment might be alleviated. Two
views were routinely performed, a medio
- lateral oblique and a super-inferior
view. All examinations were performed on either a Siemens Mammomat 2S or
a Mammomat 2U. All films were reported independently by two radiologists.
Women with suspicious lesions were recalled for assessment. Most women
recalled were reassured following further evaluation by means of clinical examin-
ation, further radiography and/ or ultrasound evaluation. Those women requiring
surgical biopsy had hospital admission arranged prior to leaving the assessment
clinic. Women who did not accept the original invitation to attend for screening
received a second invitation. Women who failed to attend following a second
invitation will be re
-invited during thenext round ofscreening inthree years' time.
RESULTS
The Table outlines the results of the first 5,000 women screened. The initial
response rate following invitation was 66% which is slightly less than the 70%
acceptance rate predicted by the Forrest Report; the recall rate of 5-2% isalmost
half that predicted. All the women screened in this report were seen in the static
screening unit. The radiographers checked all films before the women left the
department, so there were no recalls for technical reasons. All women attending
for assessment had clinical examination, some had further radiography and some
had ultrasound examination of the breasts.
TABLE
Outcome ofmammographic screening
Women invited 7,250
Women attended 5,000
Recalled for assessment 260
Requiring further radiography 184
Ultrasound examination 164-
Fine needle aspiration 42
Surgical biopsy 75
Forty-two women had fine needle aspiration performed for cytological examin-
ation. Sixteen of these aspirations were reported as consistent with malignant
disease, ten were diagnostic of benign change and the remaining sixteen did not
yield sufficient material for cytological diagnosis.
Ofthe seventy-five women who were referred forsurgical biopsy, thirty -nine had
malignant disease, andthirty
-six had benign breastchange. This isaconsiderably
more acceptable ratio than the 3:1 benign to malignant ratio predicted by the
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Forrest Report. The cancer detection rate of 7 8 per 1,000 exceeds the 5 per
1,000 required by the Pritchard Report on Quality Assurance in Mammography.6
The lower benign biopsy rate has not resulted in a lower cancer detection rate.
DISCUSSION
The Forrest Report recommended that a single oblique mammogram should be
used for screening. There have been various reports in the literature questioning
the adequacy of single view mammography,2-4 and advocating the use of two
views to decrease the number of women recalled for assessment. A survey of
the United Kingdom screening units that were operational in November 1989
revealed that 35% of centres were routinely employing two views during the
prevalence round of the National Breast Screening Programme.5 As it was
predicted that the cost of the extra view could be offset by fewer recalls,5 it
was decided that two views should be performed in the Eastern Board during
the prevalence screening round. All films are independently reported by two
radiologists in accordance with the Pritchard Report on quality assurance in
mammography6 and in accordance with 67 % of the United Kingdom breast
screening centres.7 The initial results ofthe Eastern Board Screening Programme
are encouraging and the recall rate, benign to malignant biopsy rate and cancer
detection rate exceed the Forrest expectations.
However, the response rate to the initial invitations for screening is disappointing,
but not entirely unexpected as the uptake for cervical screening in Northern
Ireland is also lower than the United Kingdom average. The lower recall rate for
assessment is welcome, not only in terms of the reduction in assessment work-
load, but in terms ofthe high anxiety generated by recall forassessment. The cost
of the extra view is more than offset by this lower recall rate and hence reduction
in the number of assessment clinics is required.5
As further experience is gained in fine needle aspiration cytology, definitive
pre-operative diagnosis will result in a reduction in the number of diagnostic
biopsies and a single surgical procedure encompassing wide local excision and
axillary lymph node sampling will become more common. Further efforts in the
field of health education and health promotion are required to improve the
number of women attending for screening. The recent report from Edinburgh
suggests that unless 70% of women attend for screening, a 30% reduction in
mortality from screening cannot be achieved.8 In view of the number of cancers
being detected in the women who attend for screening, a greater response rate
would lead to the ultimate goal of a greater reduction in the mortality from breast
cancer.
The success of the Eastern Board Breast Screening Programme has been dependent on a multi-
disciplinary approach involving radiologists, surgeons, and pathologists. The authors wish to thank
Dr M McAuley, breast clinician who carried out most ofthe clinical examinations, Mr W Odling -Smee,
Mr A J Wilkinson, Mr R A J Spence and Mr H Logan who provided surgical support, Dr P Watt and
Dr L Caughley who provided the cytological support for the programme, and the radiographic staff for
their high level of commitment.
The authors would particularly like to acknowledge the valuable role of Dr Patrick Watt, Consultant
Pathologist, who worked tirelessly during the setting up and implementation of the programme. His
untimely death on December 28th 1990 has deprived the Screening Programme in Northern Ireland
of a devoted expert in the field of breast screening.
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